Smith & Nephew

Smith & Nephew is an industry leader in each of our three main Global Business Units - Orthopaedic Reconstruction and Trauma, Endoscopy and Advanced Wound Management. These businesses jointly offer over 1,000 product ranges.

Our global infrastructure continues to expand each year. We currently operate in 32 countries and generate annual sales of $3.4 billion. Substantial investment in our products and intensive research and development means that we are always ahead. Figures from last year show that we stand at number one as the leading company in Arthroscopy. We are the second largest organisation in Advanced Wound Management and number three in Trauma and Clinical Therapies. We are also positioned at number four in reconstruction.

Smith & Nephew has a track record of bringing innovative new products to market that provide better clinical outcomes for patients and save costs for healthcare providers. This is the primary focus of our fourth business unit, Biologics.

Type
Public
HQ
London, GB
Founded
1856
Employees
14,686 (est)+5%
Smith & Nephew was founded in 1856 and is headquartered in London, GB

Key People at Smith & Nephew

Julie Brown

Julie Brown

CFO
John W. Campo

John W. Campo

CLO
Olivier Bohuon

Olivier Bohuon

CEO
Helen Maye

Helen Maye

CHRO
Philippe Mazas

Philippe Mazas

Group CIO
Rasmus Platz

Rasmus Platz

VP of Business Development
Graham Baker

Graham Baker

CFO

Smith & Nephew Locations

London, GB
São Paulo, BR
Andover, US
Memphis, US
St. Petersburg, US
Austin, US
Horsholm, DK
Midland, US
Fort Worth, US
Durham, US
Cardiff, GB
Winchester, GB
Exeter, GB
Hoofddorp, NL
Norwich, GB
Leeds, GB
Leicester, GB
Portsmouth, GB
Brighton, GB
Bristol, GB

Smith & Nephew Metrics

Smith & Nephew Summary

Market capitalization

$564 M

Closing share price

$9.32
Smith & Nephew's latest market capitalization is $564 M.

Smith & Nephew Financials

Smith & Nephew's revenue was £3.18 B in FY, 2015 which is 0.37% increase from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

£2.87 B£3.17 B£3.18 B

Revenue growth, %

10.5%0.4%

Cost of sales

£725 M£797 M£784 M

Gross profit

£2.14 B£2.37 B£2.4 B

Gross profit Margin, %

74.7%74.8%75.3%

Operating expense total

£1.61 B£1.86 B£1.96 B

Smith & Nephew Market Value History

Smith & Nephew Online Presence

Smith & Nephew News

Smith & Nephew Company Life

You may also be interested in